Article Figures & Data
Figures
- Figure 1 Overview of the Systematic Literature Search in Medline Epub
An All published work has been included until January 29, 2020, independent of the type of intervention or class of evidence given the limited number of Class I evidence studies. Data of 50 publications were included and analyzed.
- Figure 2 Relative Change in Serum Anti-MAG IgM Titers or Levels and Response to Immunotherapies in Patients With Anti-MAG Neuropathy
An overview of the studies that assessed the relative change in anti-MAG IgM autoantibodies (pretreatment and posttreatment) and clinical response to immunotherapies. (A) Relative change in anti-MAG IgM titers in the responder (a) and the nonresponder group (b); (B) Relative change in paraprotein levels in the responder and the nonresponder group; and (C) Relative change in total IgM levels in the responder and the nonresponder group. Data are indicated as mean values and the circle size represents comparative size of the study (number of participants). MAG = myelin‐associated glycoprotein.
- Figure 3 Comparison of the Relative Change in Serum anti-MAG IgM Titers or Levels Between Responder, Nonresponder, and Acute Deteriorating Groups
Comparison of clinical improvement and relative change in serum anti-MAG IgM titers, paraprotein levels, and total IgM levels in the (A) responder group, (B) nonresponder group, (C) and the acute deteriorating group. Data are shown as median and 95% confidence intervals. MAG = myelin‐associated glycoprotein.
- Figure 4 Analysis of the Clinical Study Patient Population
(A) Mean age at onset of the neuropathy and (B) the mean age at the start of the clinical study was significantly lower in the responder group (n = 208 participants) compared with the nonresponder group (n = 191 participants); (C) The difference in disease duration until the patients participated in the clinical study was not significant. Data are shown as median and 95% confidence intervals, an independent t-test and Tukey Kramer test were performed (p < 0.05).
Tables
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.